AposHealth Overview
AposHealth is developing solutions for the identification and treatment of gait-related conditions. The AposHealth foot-worn Apos3 device is FDA cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA-cleared wellness device that can help patients live well with other gait-related conditions such as chronic low back and hip pain. With a mission to advance global health through the power of movement, AposHealth's latest business unit, AposIQ, combines innovative technology, data science, and over a decade of experience in gait modification to determine the optimal way to adjust patients' gaits over time.
Cumulative Funding Raised Over Time ($)
$2.5MAug 2016
$13.5MDec 2011
$24.5MFeb 2020
$39.5MNov 2014
$44.5MOct 2013
Latest News
growth-positive
Press Release
Highmark Health is partnering with AposTherapy to bring a non-invasive, drug-free treatment option for knee osteoarthritis pain to patients. The AposTherapy device, cleared by the FDA, helps reduce knee pain and improve lower extremity function. The treatment program requires patients to wear a personalized device for one hour per day. Highmark Health aims to transform healthcare by driving better patient outcomes and lowering the total cost of care. The partnership with AposTherapy allows Highmark Health to offer an alternative non-invasive option for knee osteoarthritis treatment. The treatment is currently available to Highmark Inc. commercial health plan members in western Pennsylvania and will be explored for availability in other core markets in 2021.
PartnersCustomers
growth-positive
Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposTherapy® Designed for Use in Orthopedic Conditions
Healthfirst, New York’s largest not-for-profit health insurance company, will offer coverage for AposTherapy®, a foot-worn device for treating knee osteoarthritis and low back pain. The device temporarily shifts pressure from painful areas and provides a neuromuscular effect by re-educating muscles. Healthfirst initially provided AposTherapy® treatment to members with chronic knee pain due to osteoarthritis and later expanded coverage to members with chronic low back pain. The treatment program includes wearing the device for about an hour a day and attending physical therapy sessions. AposTherapy® is custom-calibrated for patients by trained clinicians. Recent research published in The Journal of the American Medical Association (JAMA) showed pain reduction and improvement in function for knee osteoarthritis patients treated with AposTherapy®. Healthfirst has seen lower utilization of resources, decreased pain medication use, and lower per member per month rates with the use of AposTherapy®.
CustomersPartners
growth-positive
Partnership innovates for knee conditions
Apos Medical Assets is partnering with Spirit Access to improve health outcomes for patients with chronic knee conditions in the UK. The partnership aims to make the NHS Pathway for chronic knee conditions more efficient and reduce the number of knee replacement surgeries. AposTherapy, a clinically proven non-surgical knee pain treatment, has shown promising results in avoiding surgeries, saving costs, and reducing musculoskeletal, outpatient visits, radiology, injections, and opioid use. Apos Medical Assets recognizes the need for greater market access in the UK and is excited to work with Spirit Access to make AposTherapy available to more Clinical Commissioning Groups (CCGs).
PartnersCustomers
growth-positive
Research Published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposTherapy® Experienced Significant Pain Reduction
A study conducted by researchers from Boston University School of Medicine, the University of Bern Switzerland, and the University of Toronto found that AposTherapy significantly reduced pain associated with knee osteoarthritis and improved patients physical function and stiffness. The findings provide strong evidence supporting the effectiveness of the treatment. AposTherapy is an innovative, FDA-cleared temporary treatment for knee osteoarthritis and other musculoskeletal conditions. It uses a foot-worn medical device to shift pressure away from impacted areas and improve body mechanics and muscular coordination. The company aims to provide a value-based approach to musculoskeletal conditions and help patients with pain and functional impairment.
Customers
You are being redirected...
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $37M |
| Last funding | $11M |
| Stage | Mature |
| Rounds | 5 |
| Investors | 5 |
Team Members
3
Employees: 51-200
Web & Social Links
| Website | www.aposhealth.com/ |
| Careers | Careers page |
Locations
Shderot Aba Eban 1, Herzliya, Israel
Ha-Marpe Street 1, Jerusalem, Israel
Leon Stein Street 9, Haifa, Israel
300 Park Avenue, New York, NY, USA
Photos & Videos
3 item(s)
AposHealth Business
Business models
B2C, B2B
Product stage
Released
Employees
51-200
Sector
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical Treatment & TherapeuticsAssistive DevicesTarget Customer
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatientsConsumersDemographics & FamilySeniorsDisabilitiesCore Technology
Semiconductors & ElectronicsWearablesTags (20)
orthopedicspain-reliefpersonalizationhome-caremedical-productsrehabilitationnon-surgicaltherapeutic-devicesosteoarthritispatientschronic-paindoctorstreatmentsinsurance-companieswearableseniorswellnesshealthcare-providersremote-monitoringdigital-healthcareGeographic Markets
United KingdomUnited StatesSingaporeAposHealth Financials
$37M
Total funding
Undisclosed
Capital raised
$11M
Last funding
Mature
Funding stage
5
Total rounds
5
Investors
Cumulative Funding Raised Over Time ($)
$2.5MAug 2016
$13.5MDec 2011
$24.5MFeb 2020
$39.5MNov 2014
$44.5MOct 2013
Private Equity Funding
A Round
Feb 2020
$11M
aMoon Fund
Debt Financing
Aug 2016
$2.5M
A Round
Nov 2014
$15M
Aviv Venture Capital, Invus, Pitango VC
Debt Financing
Oct 2013
$5M
Viola Credit
A Round
Dec 2011
$11M
Pitango VC, Aviv Venture Capital
AposHealth Lifecycle
Cumulative Funding Raised Over Time
$2.5MAug 2016
$13.5MDec 2011
$24.5MFeb 2020
$39.5MNov 2014
$44.5MOct 2013
All Events
A Round
Feb 2020
$11M
aMoon Fund
Debt Financing
Aug 2016
$2.5M
A Round
Nov 2014
$15M
Aviv Venture Capital, Invus, Pitango VC
Debt Financing
Oct 2013
$5M
Viola Credit
A Round
Dec 2011
$11M
Pitango VC, Aviv Venture Capital
AposHealth News
12 articles
growth-positive
Press Release
Highmark Health is partnering with AposTherapy to bring a non-invasive, drug-free treatment option for knee osteoarthritis pain to patients. The AposTherapy device, cleared by the FDA, helps reduce knee pain and improve lower extremity function. The treatment program requires patients to wear a personalized device for one hour per day. Highmark Health aims to transform healthcare by driving better patient outcomes and lowering the total cost of care. The partnership with AposTherapy allows Highmark Health to offer an alternative non-invasive option for knee osteoarthritis treatment. The treatment is currently available to Highmark Inc. commercial health plan members in western Pennsylvania and will be explored for availability in other core markets in 2021.
PartnersCustomers
growth-positive
Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposTherapy® Designed for Use in Orthopedic Conditions
Healthfirst, New York’s largest not-for-profit health insurance company, will offer coverage for AposTherapy®, a foot-worn device for treating knee osteoarthritis and low back pain. The device temporarily shifts pressure from painful areas and provides a neuromuscular effect by re-educating muscles. Healthfirst initially provided AposTherapy® treatment to members with chronic knee pain due to osteoarthritis and later expanded coverage to members with chronic low back pain. The treatment program includes wearing the device for about an hour a day and attending physical therapy sessions. AposTherapy® is custom-calibrated for patients by trained clinicians. Recent research published in The Journal of the American Medical Association (JAMA) showed pain reduction and improvement in function for knee osteoarthritis patients treated with AposTherapy®. Healthfirst has seen lower utilization of resources, decreased pain medication use, and lower per member per month rates with the use of AposTherapy®.
CustomersPartners
growth-positive
Partnership innovates for knee conditions
Apos Medical Assets is partnering with Spirit Access to improve health outcomes for patients with chronic knee conditions in the UK. The partnership aims to make the NHS Pathway for chronic knee conditions more efficient and reduce the number of knee replacement surgeries. AposTherapy, a clinically proven non-surgical knee pain treatment, has shown promising results in avoiding surgeries, saving costs, and reducing musculoskeletal, outpatient visits, radiology, injections, and opioid use. Apos Medical Assets recognizes the need for greater market access in the UK and is excited to work with Spirit Access to make AposTherapy available to more Clinical Commissioning Groups (CCGs).
PartnersCustomers
growth-positive
Research Published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposTherapy® Experienced Significant Pain Reduction
A study conducted by researchers from Boston University School of Medicine, the University of Bern Switzerland, and the University of Toronto found that AposTherapy significantly reduced pain associated with knee osteoarthritis and improved patients physical function and stiffness. The findings provide strong evidence supporting the effectiveness of the treatment. AposTherapy is an innovative, FDA-cleared temporary treatment for knee osteoarthritis and other musculoskeletal conditions. It uses a foot-worn medical device to shift pressure away from impacted areas and improve body mechanics and muscular coordination. The company aims to provide a value-based approach to musculoskeletal conditions and help patients with pain and functional impairment.
Customers
You are being redirected...
growth-positive
AposTherapy® Expands Partnership With Professional Physical Therapy to Offer Its Drug-Free Solution to Knee and Low Back Pain Patients at Additional Massachusetts Locations
AposTherapy has partnered with Professional Physical Therapy to offer a non-invasive, drug-free alternative to surgery for Massachusetts residents suffering from knee and low back pain. The program is available to members of Blue Cross Blue Shield of Massachusetts commercial, fully insured accounts. The AposTherapy program combines a patented footworn medical device and treatment program to address pain at the source and reeducate muscles for a healthier walking pattern. Clinical studies have shown significant reduction in pain and improvement in function and quality of life. The partnership aims to provide relief for knee and low back pain without opioids or invasive procedures.
Partners
growth-positive
AposTherapy® Partners With Three Physical Therapy Providers in Queens to Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in New York
AposTherapy has partnered with three local physical therapy providers in Queens, New York to offer a non-invasive, drug-free alternative to surgery for residents suffering from knee and lower back pain. The program is available at All Hands on Physical Therapy, Sungil Hong PT, and Hands of Hope clinics. AposTherapy is an FDA-cleared treatment for knee osteoarthritis and other musculoskeletal conditions. It utilizes a foot-worn medical device and a treatment program to address the underlying causes of pain and improve function and quality of life. The partnerships aim to meet the growing need for knee pain relief without drugs or invasive procedures.
Partners
growth-positive
AposTherapy® and Ahava Medical & Rehabilitation Center Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in Brooklyn
Ahava Medical & Rehabilitation Center has partnered with AposTherapy to offer a non-invasive, drug-free alternative treatment for knee and lower back pain. The AposTherapy program combines a foot-worn medical device and a treatment program to address pain at the source and re-educate muscles for a healthier walking pattern. Clinical studies have shown significant reduction in pain and improvement in function and quality of life. Ahava Medical & Rehabilitation Center aims to provide personalized care to their community through this partnership.
Customers
growth-positive
AposTherapy Launches Unique Patient Activation Program
AposTherapy and GoMo Health have launched the AposTherapy Concierge Care Program, a virtual care coordinator that guides patients through their healthcare journey. The program is expected to improve patient activation and outcomes while reducing the cost of healthcare delivery. AposTherapy is using GoMo Healths BehavioralRx patient engagement system to provide a seamless patient experience. The program offers personalized guidance, tips, and encouragement to patients based on their stage of the treatment process. AposTherapy is an innovative treatment for knee osteoarthritis and other musculoskeletal conditions. It works by shifting pressure away from painful areas and re-educating muscles to a healthier walking pattern. The treatment has shown significant pain relief and improvement in daily function and quality of life.
Customers
growth-positive
Apos Medical Assets Ltd. Announces $11 Million Series A Extension Funding Round Led by Existing Shareholders
Apos Medical Assets Ltd., a global medical device company, has raised $11 million in a new funding round. The funding will be used to support the companys rapid expansion into new territories, increase sales capabilities, and invest in research and development for the next generation AposTherapy® device. AposTherapy® is an FDA-cleared treatment for knee osteoarthritis and other musculoskeletal conditions. The treatment combines a foot-worn medical device with a treatment program to provide pain relief and improve daily function and quality of life. With the funding, Apos Medical Assets Ltd. aims to increase distribution, payer coverage, and bring enhanced products and capabilities to the market.
InvestmentExpand
growth-positive
Apos Therapy catches the eye of ex-pro athletes
Apos Therapy, an Israeli company, has developed a non-invasive at-home system for reducing joint pain. The system, which uses adjustable pods in the soles of boots to create a subtle imbalance, trains the brain to re-position muscles and correct back, hip, and knee alignment. Former pro athletes, including Tom Satch Sanders, have tried Apos Therapy and reported immediate relief. Over 80% of surveyed Apos patients in the UK reported a reduction in pain. Apos is now training physical therapists in the US to use their system, taking advantage of the existing infrastructure for physical therapy. The therapy is not currently covered by medical insurance in the US and costs up to $6,000.
CustomersPartners
growth-positive
Knee, back treatment co AposTherapy raises $15m
AposTherapy, a company that uses individually calibrated shoes to treat knee and back pain, has completed a $15 million financing round at an estimated $100 million company value. The company has raised $30 million to date and has 140 employees. AposTherapy is currently marketing its services in Israel, the UK, Singapore, the US, and other countries. The company is now focusing on expanding its business in the US market and plans to transfer its service activity to physiotherapy institutes while concentrating on research and development. AposTherapys treatment competes with pain relievers and complex surgery for ending pain, and the companys studies show that 86% of users reported less pain within five weeks.
InvestmentExpand
AposHealth Team
Employee Info
| Employees (range) | 51-200 |
| Exact count | 116 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 17 classification IDs that could be used for matching.
AposHealth Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 514531508 |
| Crunchbase | apostherapy |
| Phone | +97299615100 |
| Creator | Tamar Weiss |
| Creator email | tamar.e.weiss@gmail.com |
| Last updater | Yotam Maman |
| Updater email | yotamm1988@gmail.com |
| Last update | 2021-01-04T00:00:00.000Z |
| Created | 2014-07-15T00:00:00.000Z |